Clinical Trial Update: Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating saxagliptin for glycemic control in non-critically ill hospitalized patients has completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Saxagliptin (Onglyza) (saxagliptin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-06-01